Our Story
We need more data.
Let's go get it.
The Challenges
Over the past few years we have repeatedly seen the bottlenecks, hurdles, and pain points the industry continues to experience with regards to the discovery of new medicines. Whenever a disease is studied, it is reduced to a problematic biological macromolecule that has gone awry, either by being too active, too inactive, broken, or in the wrong place.
Every time a discovery program is launched, immense amounts of capital are required, teams of industry veterans are needed, and endless scientific debates commence to figure out to develop a new therapeutic with the right mechanism of action.
The Solution
Screen biology broadly, and make the data broadly accessible so programs can be launched, fast.
Our Solution
Purpose Built for ML
The revolutionary capabilities offered by ML are transforming industries . We want to harness these capabilities and provide the needed data and training sets for ML, to unleash our ability to discover much needed medicines for patients. We are focused on building next-generation tools and capabilities to provide access to discovery to researchers across the globe.

Investors
Partners

Founders

Devon Cayer
CEO
Serial entrepreneur, scientist, previously raising >$50M with success in establishing both a platform and several partnerships

Adam Bouzaffour
Head of Operations
Expertise in genomics, NGS, assay development, molecular biology, and guided encoded library screening platform builds.